Le Lézard10h
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to SOTIO Biotech, a ...
Le Lézard10h
SimBioSys Appoints Stacey Stevens as President and CEO
SimBioSys, a pioneering TechBio company revolutionizing cancer care with advanced AI and spatial biophysics, today announced the appointment of AI-driven medical device ...